» Articles » PMID: 30410607

Roles of Smads Family and Alternative Splicing Variants of Smad4 in Different Cancers

Overview
Journal J Cancer
Specialty Oncology
Date 2018 Nov 10
PMID 30410607
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming Growth Factor β (TGF-β) is one of the most common secretory proteins which are recognized by membrane receptors joined to transcription regulatory factor. TGF-β signals are transduced by the Smads family that regulate differentiation, proliferation, early growth, apoptosis, homeostasis, and tumor development. Functional study of TGF-β signaling pathway and Smads role is vital for certain diseases such as cancer. Alternative splicing produces a diverse range of protein isoforms with unique function and the ability to react differently with various pharmaceutical products. This review organizes to describe the general study of Smads family, the process of alternative splicing, the general aspect of alternative splicing of Smad4 in cancer and the possible use of spliceoforms for the diagnosis and therapeutic purpose. The main aim and objective of this article are to highlight some particular mechanisms involving in alternatives splicing of cancer and also to demonstrate new evidence about alternative splicing in different steps given cancer initiation and progression.

Citing Articles

Outcomes of patients with Juvenile Polyposis-Hereditary Haemorrhagic Telangiectasia caused by pathogenic SMAD4 variants in a pan-Scotland cohort.

Pearson M, McGowan R, Greene P, Lam W, Miedzybrodzka Z, Berg J Eur J Hum Genet. 2024; 32(6):731-735.

PMID: 38627541 PMC: 11153582. DOI: 10.1038/s41431-024-01607-w.


Exitrons: offering new roles to retained introns-the novel regulators of protein diversity and utility.

Shamnas V M, Singh A, Kumar A, Mishra G, Sinha S AoB Plants. 2024; 16(2):plae014.

PMID: 38566894 PMC: 10985678. DOI: 10.1093/aobpla/plae014.


Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma.

Albalawi A, Alatawi A, Al-Atwi S, Alhwyty L, Alharbi K, Alshehri S Biomol Biomed. 2024; 24(5):1186-1198.

PMID: 38461536 PMC: 11379005. DOI: 10.17305/bb.2024.10367.


Recent progress in metabolic reprogramming in gestational diabetes mellitus: a review.

Xie Y, Lin S, Xie B, Zhao H Front Endocrinol (Lausanne). 2024; 14:1284160.

PMID: 38234430 PMC: 10791831. DOI: 10.3389/fendo.2023.1284160.


Combined Inhibition of the TGF-β1/Smad Pathway by and to Reduce Inflammation and Fibrosis in Primary Sclerosing Cholangitis.

Shen Y, Jiang B, Zhang C, Wu Q, Li L, Jiang P Int J Mol Sci. 2023; 24(13).

PMID: 37446187 PMC: 10341692. DOI: 10.3390/ijms241311010.


References
1.
Bhowmick N, Ghiassi M, Bakin A, Aakre M, Lundquist C, Engel M . Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001; 12(1):27-36. PMC: 30565. DOI: 10.1091/mbc.12.1.27. View

2.
Lazzereschi D, Nardi F, Turco A, Ottini L, DAmico C, Mariani-Costantini R . A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours. Oncogene. 2005; 24(34):5344-54. DOI: 10.1038/sj.onc.1208603. View

3.
Weinstein M, Yang X, Deng C . Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev. 2000; 11(1-2):49-58. DOI: 10.1016/s1359-6101(99)00028-3. View

4.
Hruban R, Wilentz R, Goggins M, Offerhaus G, Yeo C, Kern S . Pathology of incipient pancreatic cancer. Ann Oncol. 1999; 10 Suppl 4:9-11. View

5.
Brinkman B . Splice variants as cancer biomarkers. Clin Biochem. 2004; 37(7):584-94. DOI: 10.1016/j.clinbiochem.2004.05.015. View